Stay updated on Immunotherapy Combinations in Metastatic Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Immunotherapy Combinations in Metastatic Lung Cancer Clinical Trial page.

Latest updates to the Immunotherapy Combinations in Metastatic Lung Cancer Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedAdded core results content (Adverse Events, Outcome Measures, Baseline Characteristics, Participant Flow) and status/contacts updates to the study record, with a QC note and revision to v3.5.2 dated 2026-04-10.SummaryDifference0.6%

- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedAdded a 'Results Submitted' entry and updated the revision to v3.5.0. This replaces the previous 'No Results Posted' status tied to v3.4.3.SummaryDifference0.1%

- Check48 days agoChange DetectedRevision tag v3.4.3 was added and v3.4.2 was removed.SummaryDifference0.0%

- Check77 days agoChange DetectedA new revision (v3.4.2) was added to the history, and two older administrative notices (including a funding lapse notice) were removed.SummaryDifference0.3%

- Check84 days agoChange DetectedAdded a government funding lapse notice at the top of the page and updated the page revision from v3.4.0 to v3.4.1.SummaryDifference0.3%

- Check91 days agoChange DetectedRecord History page now includes a glossary display option, color-coding for changes (additions/deletions) and a new Revision: v3.4.0 tag, along with the addition of No FEAR Act Data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to Immunotherapy Combinations in Metastatic Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Immunotherapy Combinations in Metastatic Lung Cancer Clinical Trial page.